Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elevance Health Inc.

    NYSE: ANTM · Real-Time Price · USD
    482.58
    12.71 (2.71%)
    At close: Jun 28, 2022, 6:00 AM

    Elevance Health Statistics

    Share Statistics

    Elevance Health has 237.46M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 237.46M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 237.04M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 14.37 and the forward PE ratio is null. Elevance Health's PEG ratio is 6.15.

    PE Ratio

    n/a
    		 14.37

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.49

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.08

    P/FCF Ratio

    n/a
    		 18.87

    PEG Ratio

    n/a
    		 6.15
    Financial Ratio History

    Enterprise Valuation

    Elevance Health has an Enterprise Value (EV) of 108.85B.

    EV / Sales

    n/a
    		 0.62

    EV / EBITDA

    n/a
    		 11.98

    EV / EBIT

    n/a
    		 18.74

    EV / FCF

    n/a
    		 23.91

    Financial Position

    The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.76.

    Current Ratio

    n/a
    		 2.01

    Quick Ratio

    n/a
    		 2.01

    Debt / Equity

    n/a
    		 0.76

    Debt / EBITDA

    n/a
    		 3.44

    Debt / FCF

    n/a
    		 6.86

    Interest Coverage

    n/a
    		 6.67

    Financial Efficiency

    Return on Equity is 14.47% and Return on Invested Capital is 6.44%.

    Return on Equity

    n/a
    		 14.47%

    Return on Assets

    n/a
    		 5.12%

    Return on Invested Capital

    n/a
    		 6.44%

    Revenue Per Employee

    n/a
    		 $1,800,509.16

    Profits Per Employee

    n/a
    		 $60,896.13

    Employee Count

    n/a
    		 98,200

    Asset Turnover

    n/a
    		 1.51

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.93B

    Effective Tax Rate

    n/a
    		 24.46%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.97, so Elevance Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.97

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 493.45

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 51.21

    Average Volume (20 Days)

    n/a
    		 1,177,335

    Income Statement

    In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 26.29.

    Revenue

    n/a
    		 176.81B

    Gross Profit

    n/a
    		 157.06B

    Operating Income

    n/a
    		 7.9B

    Net Income

    n/a
    		 5.98B

    EBITDA

    n/a
    		 9.09B

    EBIT

    n/a
    		 9.09B

    Earnings Per Share (EPS)

    n/a
    		 26.29
    Full Income Statement

    Balance Sheet

    The company has 8.29B in cash and 31.23B in debt, giving a net cash position of -22.94B.

    Cash & Cash Equivalents

    n/a
    		 8.29B

    Total Debt

    n/a
    		 31.23B

    Net Cash

    n/a
    		 -22.94B

    Retained Earnings

    n/a
    		 33.55B

    Total Assets

    n/a
    		 100.82B

    Working Capital

    n/a
    		 29.28B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 5.81B and capital expenditures -1.26B, giving a free cash flow of 4.55B.

    Operating Cash Flow

    n/a
    		 5.81B

    Capital Expenditures

    n/a
    		 -1.26B

    Free Cash Flow

    n/a
    		 4.55B

    FCF Per Share

    n/a
    		 19.55
    Full Cash Flow Statement

    Margins

    Gross margin is 88.83%, with operating and profit margins of 4.47% and 3.38%.

    Gross Margin

    n/a
    		 88.83%

    Operating Margin

    n/a
    		 4.47%

    Pretax Margin

    n/a
    		 4.47%

    Profit Margin

    n/a
    		 3.38%

    EBITDA Margin

    n/a
    		 5.14%

    EBIT Margin

    n/a
    		 4.47%

    FCF Margin

    n/a
    		 2.57%

    Dividends & Yields

    ANTM pays an annual dividend of $5.95, which amounts to a dividend yield of 0.99%.

    Dividend Per Share

    n/a
    		 $5.95

    Dividend Yield

    n/a
    		 0.99%

    Dividend Growth (YoY)

    n/a
    		 13.27%

    Payout Ratio

    n/a
    		 23.42%

    Earnings Yield

    n/a
    		 6.96%

    FCF Yield

    n/a
    		 5.3%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ANTM.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 1, 2005. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Jun 1, 2005

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 3.57

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist